跳至主要内容
临床试验/NCT04867460
NCT04867460
终止
不适用

Ultrasound-guided Venous Access, Using a Wireless Probe, for Pacemaker and Defibrillator Implants - a Randomized Study

Region Skane1 个研究点 分布在 1 个国家目标入组 58 人2021年4月1日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Cardiac Arrhythmia
发起方
Region Skane
入组人数
58
试验地点
1
主要终点
Mean time to complete venous access
状态
终止
最后更新
去年

概览

简要总结

The study will include patients scheduled for transvenous pacemaker- or implantable defibrillator surgery, where venous access is necessary for lead implantation. A 1:1 randomization will be performed to either standard access (at the discretion of the surgeon) or ultrasound-guided using a wireless vascular transducer (Siemens Freestyle). Primary outcome is mean time to vascular access. In addition, success rate, complication rate and total procedure time will be measured.

详细描述

Pacemaker- and defibrillator lead implants typically involve vascular access via the left cephalic, axillar or subclavian vein. Gaining access is usually straight forward for an experienced surgeon/implanter, but can be difficult in a minority of cases, or for implanters with less experience. Complications include arterial puncture, pneumothorax and local bleeding or hematoma. Traditionally cephalic vein cut-down is the first choice, but is only available in 70% of cases, and for more complex procedures involving three electrodes, an additional access is always required. Ultrasound guidance is very common in other vascular access areas such as femoral artery, radial artery and internal jugular vein, but has not gained widespread acceptance in pacemaker procedures. High quality studies, demonstrating superiority or non-inferiority over other access methods are lacking. The present study will include all comer patients scheduled for transvenous pacemaker- or implantable defibrillator surgery, where venous access is necessary for lead implantation. A 1:1 randomization will be performed to either standard access (at the discretion of the surgeon) or ultrasound-guided using a wireless vascular transducer (Siemens Freestyle). Implanters with various degrees of ultrasound experience and pacemaker surgery experience will participate in the study. All implanters will receive a 2-hour training lecture and additional hands-on training for the first 3 cases, by an ultrasound-experienced anaesthesiologist. Access time and success rate will be recorded, and all acute complications will be recorded. Primary outcome is mean time to vascular access. In addition, success rate, complication rate and total procedure time will be measured. Outcome data will be analyzed for the entire cohort, but also stratified for implanter and excluding the first 10 cases for each implanter, to compensate for various experience and individual learning curve.

注册库
clinicaltrials.gov
开始日期
2021年4月1日
结束日期
2025年2月27日
最后更新
去年
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
Region Skane
责任方
Sponsor

入排标准

入选标准

  • Planned pacemaker or implantable defibrillator surgery with at least one new transvenously placed lead.

排除标准

  • Difficult vascular access known before surgery, where special access technique is planned or required.

结局指标

主要结局

Mean time to complete venous access

时间窗: Peroperatively

Time from start of vascular access attempt to achieved access for the required number access points (ie number of leads)

次要结局

  • Mean time to first venous access(Peroperatively)
  • Successrate for full venous access(Peroperatively)
  • Successrate for full venous access within 3 minutes(Peroperatively)
  • Full venous access without any complication(Peroperatively within 24 hours)

研究点 (1)

Loading locations...

相似试验